Ignite Creation Date:
2025-12-24 @ 11:18 PM
Ignite Modification Date:
2026-06-21 @ 5:29 PM
Study NCT ID:
NCT04815356
Status:
RECRUITING
Last Update Posted:
2025-11-10
First Post:
2021-03-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Study of Anti-CD22 Chimeric Receptor T Cells in Patients With Relapsed/Refractory Hairy Cell Leukemia and Variant
Sponsor:
Organization: